New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
The FDA has authorized the first at-home testing kits for gonorrhea, chlamydia, and trichomoniasis, along with new gonorrhea ...
Please provide your email address to receive an email when new articles are posted on . Patients often received treatments that are not recommended by the CDC, particularly azithromycin. Keeping up ...
Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care practices, ...
Chlamydia is often called a “silent infection” because many people don’t know they have it. It’s caused by a type of bacteria called Chlamydia trachomatis and can affect both men and women. While it’s ...
Researchers at Umeå University, Sweden, and Michigan State University, USA, have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health. The ...
"About 80% of people with chlamydia don't develop symptoms," notes Dr. Michael Shen, an internal medicine physician at NYC Health + Hospitals/Brooklyn. But when symptoms do occur, they typically ...
Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results